Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Anat Rec (Hoboken). 2015 Feb 17;298(5):865–877. doi: 10.1002/ar.23105

TABLE 2.

SERUM AND URINE MEASUREMENTS IN MEDULARY SPONGE KIDNEY STONE FORMERS

Case SERUM URINE
Creat
mg/dl
K
mmol/L
HCO3
meq/L
Vol
l/day
pH Calcium
mg/d
Oxalate
mg/d
Citrate
mg/d
Sulfate
meq/d
NH4
mmol/d
Ca/Cr
mg/gm
SS
CaOx
SS CaP
1 1.0 4.0 24 3.16 5.96 275 49 347 51 58 142 5.62 0.63
2 0.6 4.2 24 1.41 5.48 239 28 931 43 31 201 9.22 0.87
3 1.4 3.7 31 3.41 6.55 212 56 285 33 32 94 5.53 0.90
4 0.5 3.2 26 1.29 6.30 229 43 285 35 39 214 12.1 2.30
5 0.7 3.9 27 1.55 6.11 164 24 519 36 36 138 5.19 0.95
6 0.7 4.1 28 1.42 5.95 240 37 685 44 29 184 10.58 1.22
7 0.7 4.4 24 2.80 5.93 149 40 548 17 34 135 4.45 0.22
8 1.0 4.0 24 1.73 6.09 272 33 994 30 23 187 7.51 1.47
9 0.9 4.2 28 2.21 5.92 199 30 255 31 30 93 4.41 0.69
10 1.0 4.5 25 3.72 6.10 231 38 806 26 24 207 3.45 0.35
11 1.2 4.1 24 3.50 6.32 473 62 2370 58 53 199 8.30 1.83
12 - - - 1.30 6.30 324 31 536 30 18 252 11.1 3.65
Mean 0.9±0.1 4.0 ± 0.1 26 ± 0.7 2.3±0.2 6.1±0.1 250±18 39±3 641±76 36±2 34±2 170±13 7.3±0.8 1.3±0.3

Data for each patient is the mean of two 24 hour urines done off medications; a single serum was measured for each patient. Values are means and SEM. Creat, creatinine; Vol, volume; NH4, ammonium; Ca, calcium; Cr, creatinine; SS, supersaturation; CaOx, calcium oxalate; CaP, calcium phosphate.